Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events weighing patient doctor benefit risk preferences psoriasis treatments
2022 World Symposium on Lysosomal Disease Share on: Monday, February 7 - Friday, February 11, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 2022 World Symposium on Lysosomal Disease. Clinical …
ESMO Asian Congress 2023 Share on: Friday, December 1 - Sunday, December 3, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the ESMO Asian Congress 2023. Treatment (tx) patterns and outcomes in resectable …
… the environment. She has conducted research to investigate preferences for medical treatments, disease treatment and prevention programs, … quality protection, recreation experiences, and terrorism risk. Dr. Mansfield has extensive experience with …
… a Marketing Specialist with RTI-HS. Ms. Howze’s focus is events, project managements, and content creation. She has a … su ch as The Washington Post , The Huffington Post , U.S. News & World Report , and MTV News. …
European Lung Cancer Congress (ELCC) 2024 Share on: Wednesday, March 20 - Saturday, March 23, 2024 Conference website Research coauthored by RTI Health Solutions experts will be presented at the European Lung Cancer Congress (ELCC) 2024. Treatment (tx) …
2022 American Society of Clinical Oncology (ASCO) Annual Meeting Share on: Friday, June 3 - Wednesday, June 8, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 2022 American Society of Clinical …
… by the level of certainty and comparative net health benefit. We conducted a systematic review of evidence reports … warranted to better characterize and quantify the health benefit needed to achieve each clinical rating. See how we …
… Netherlands Related Services Pharmacoepidemiology and Risk Management Real-World Evidence Staff Members Susana …
… reimbursement decisions. Cost-effectiveness models for AD treatments face the common challenge of predicting long-term patient-relevant outcomes from short-term clinical trial … that explicitly focus on how treatment effects for new AD treatments are used in cost-effectiveness models. Such …
… Susana Perez-Gutthann Pharmacoepidemiology and Risk Management Rheumatology Barcelona, Spain MD, Medicine … and research programs for safety, pharmacovigilance, risk management, development, real world evidence, and … Good Pharmacoepidemiology Practice, and confidentiality of patient databases in Europe. Currently, Dr. Perez-Gutthann …